Azilsartan compared to ACE inhibitors in anti-hypertensive therapy: one-year outcomes of the observational EARLY registry

BACKGROUND: Azilsartan medoxomil (AZL-M), has been demonstrated to be more effective than the other sartans currently in use; however, there is insufficient information available comparing it with ACE-inhibitors. Therefore, we aimed to compare the efficacy, safety, and tolerability of AZL-M with tha...

Full description

Saved in:
Bibliographic Details
Published in:BMC Cardiovasc Disord
Main Authors: Gitt, Anselm K., Bramlage, Peter, Potthoff, Sebastian A., Baumgart, Peter, Mahfoud, Felix, Buhck, Hartmut, Ehmen, Martina, Ouarrak, Taoufik, Senges, Jochen, Schmieder, Roland E.
Format: Artigo
Language:Inglês
Published: BioMed Central 2016
Subjects:
Research Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4784379/
https://ncbi.nlm.nih.gov/pubmed/26956148
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12872-016-0222-6
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items